Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $33.25M in the quarter ending September 30, 2024, with 47.76% growth. This brings the company's revenue in the last twelve months to $112.53M, up 81.55% year-over-year. In the year 2023, Rhythm Pharmaceuticals had annual revenue of $77.43M with 227.56% growth.

• Revenue (ttm): $112.53M
• Revenue Growth: +81.55%
• P/S Ratio: 30.12
• Revenue / Employee: $497,920
• Employees: 226
• Market Cap: 3.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.